论文部分内容阅读
目的探讨26例非小细胞肺癌胸腰椎转移患者的手术治疗特点及相关预后因素。方法对非小细胞肺癌胸腰椎转移外科治疗患者26例进行回顾性分析。结果所有26例患者,生存时间3～34个月,中位生存时间12个月,1年生存率49%。单发胸腰椎转移患者的生存期明显长于多发胸腰椎转移者(P=0.015)。肿瘤的病理类刑、原发肿瘤(T)和淋巴结转移情况(N)与生存期并无关系。结论对非小细胞肺癌单发胸腰椎转移者,积极的手术治疗可使患者获益。
Objective To investigate the surgical treatment of 26 patients with non-small cell lung cancer with thoracolumbar metastasis and related prognostic factors. Methods A retrospective analysis of 26 patients with non-small cell lung cancer thoracolumbar metastasis surgical treatment. Results All 26 patients had a survival time of 3 to 34 months, a median survival time of 12 months and a 1-year survival rate of 49%. Patients with single thoracolumbar metastasis had significantly longer survival than those with multiple thoracolumbar metastases (P = 0.015). Tumor pathology type of punishment, primary tumor (T) and lymph node metastasis (N) and survival has nothing to do. Conclusion For patients with non-small cell lung cancer with single thoracolumbar metastasis, positive surgical treatment can benefit patients.